Approval · Notice of Compliance 3616 · 2003
TEMAZEPAM: Notice of Compliance 3616
Issued April 28, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3616
- Date
- April 28, 2003
- Company
- Prempharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Hypnotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEMAZEPAM | 02247526 | — |
| TEMAZEPAM | 02247527 | — |